Used in the synthesis of boron-containing pharmaceuticals, particularly in the development of protease inhibitors and targeted cancer therapies. Its boronic acid group enables reversible interactions with biological targets such as enzymes, making it valuable in drug design for conditions like diabetes and oncology. Commonly employed in Suzuki-Miyaura cross-coupling reactions during medicinal chemistry research to build complex molecules. Also serves as an intermediate in creating peptide mimetics due to the presence of both amino and carboxylic acid functionalities protected and activated in specific ways.